The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


RELISTOR

12/0.6 milligram(s)/millilitre Solution for injection

Bausch Health Ireland LimitedEU/1/08/463/1-3

Main Information

Trade NameRELISTOR
Active SubstancesMethylnaltrexone bromide
Strength12/0.6 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderBausch Health Ireland Limited
Licence NumberEU/1/08/463/1-3

Group Information

ATC CodeA06AH Peripheral opioid receptor antagonists
A06AH01 methylnaltrexone bromide

Status

Authorised/WithdrawnAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back